Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Is the cPLA2 gene associated with schizophrenia

    J Wei, K-H Lee, G P Hemmings in Molecular Psychiatry (1998)

  2. No Access

    Article

    Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study

    Factors that enhance hypercoagulability following BMT may have a pathogenetic role in VOD. To investigate the relevance of hemostatic parameters for the development of VOD, we prospectively measured protein C,...

    J-H Lee, K-H Lee, S Kim, J-S Lee, W-K Kim, C-J Park, H-S Chi in Bone Marrow Transplantation (1998)

  3. No Access

    Article

    Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation

    We performed a randomized trial to determine whether there are differential effects of G-CSF when it is either started on the day (day 0 group) or on the 6th day of marrow infusion (day 5 group) in the allogen...

    K-H Lee, J-H Lee, S-J Choi, S Kim, J-S Lee, S-H Kim, W-K Kim in Bone Marrow Transplantation (1999)

  4. No Access

    Article

    Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation

    Delayed erythropoiesis and pure red cell aplasia (PRCA) have been reported after major ABO-incompatible BMT. We attempted to find risk factors for the development of PRCA in 27 patients who underwent major ABO...

    J-H Lee, K-H Lee, S Kim, J-S Lee, S-H Kim, S-W Kwon, W-K Kim in Bone Marrow Transplantation (2000)

  5. No Access

    Article

    High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation

    We investigated the frequency and mode of relapses of acute leukemia after allogeneic BMT in a series of 50 consecutive patients. The median age of patients was 31.5 years with 26 males. Thirty-two patients ha...

    K-H Lee, J-H Lee, S Kim, J-S Lee, S-H Kim, W-K Kim in Bone Marrow Transplantation (2000)

  6. No Access

    Article

    Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study

    Hematopoietic chimerism as a predictive marker for the relapse of acute leukemia after allogeneic BMT was evaluated in a prospective study. Monthly assays of hematopoietic chimerism were performed from periphe...

    S-J Choi, K-H Lee, J-H Lee, S Kim, H-J Chung, J-S Lee in Bone Marrow Transplantation (2000)

  7. No Access

    Article

    Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia

    There are few reports about the occurrence of hepatic VOD after BMT for severe aplastic anemia (SAA). We prospectively studied 17 patients with SAA after allogeneic BMT for the occurrence and severity of VOD. ...

    J-H Lee, K-H Lee, S-J Choi, Y-J Min, J-G Kim, S Kim, J-S Lee in Bone Marrow Transplantation (2000)

  8. No Access

    Article

    Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome

    We retrospectively studied 227 patients with MDS (1) to identify the prognostic factors of survival and acute leukemia evolution in Korean patients with MDS, (2) to apply different prognostic scoring systems t...

    J-H Lee, J-H Lee, Y-R Shin, J-S Lee, W-K Kim, H-S Chi, C-J Park, E-J Seo in Leukemia (2003)

  9. No Access

    Article

    Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation

    Hematopoietic chimerism (HpC) was assayed monthly using a sensitive, polymerase chain reaction (PCR) -based method in consecutive patients. Between January 1998 and April 2002, 181 patients underwent non-T cel...

    K-H Lee, J-H Lee, S-J Choi, J-H Lee, S Kim, M Seol, Y-S Lee in Bone Marrow Transplantation (2003)

  10. No Access

    Article

    Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: a retrospective review of 216 patients

    To evaluate the significance of clinical abnormalities occurring during the peri-engraftment period following allogeneic hematopoietic cell transplantation (HCT), we retrospectively analyzed the data of 216 al...

    S-J Choi, K-H Lee, J-H Lee, J-H Lee, S Kim, M Seol, Y-S Lee in Bone Marrow Transplantation (2003)

  11. No Access

    Article

    Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course

    A total of 118 consecutive adult patients with acute leukemia (78 AML, 36 ALL, and four acute mixed lineage leukemia) underwent allogeneic hematopoietic cell transplantation (HCT) after conditioning with BuCy (n=...

    K-H Lee, J-H Lee, S-J Choi, J-H Lee, S Kim, M Seol, Y-S Lee in Bone Marrow Transplantation (2003)

  12. No Access

    Article

    Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation – frequency and outcomes

    The outcomes of patients who experience the failure to reconstitute a trilineage of blood cells after initial neutrophil engraftment were evaluated in 178 patients with hematologic disorders, who underwent all...

    K-H Lee, J-H Lee, S-J Choi, J-H Lee, S Kim, M Seol, Y-S Lee in Bone Marrow Transplantation (2004)

  13. Article

    50 Utility of Rapid B-Type Natriuretic Peptide Assay for Diagnosis of Symptomatic Patent Ductus Arteriosus in Preterm Infants

    Background/aims: In preterm infants, the rapid and accurate determination of the presence of a hemodynamically significant patent ductus arteriosus (hsPDA) is extremely important, but this is often difficult. Pla...

    B M Choi, K H Lee, B L Eun, K H Yoo, Y S Hong, C S Son, J W Lee in Pediatric Research (2004)

  14. No Access

    Article

    Influence of maternal serum levels of vitamins C and E during the second trimester on birth weight and length

    Objective: It has been known that maternal oxidative stress during pregnancy plays an important role in fetal growth. However, the association between antioxidant vitamin levels and birth outcomes is not conclusi...

    B E Lee, Y C Hong, K H Lee, Y J Kim, W K Kim in European Journal of Clinical Nutrition (2004)

  15. No Access

    Article

    Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study

    The role of methotrexate (MTX), given with cyclosporine (CS), after HLA-identical sibling bone marrow transplantation needs to be defined. In all, 80 patients with hematologic malignancies were enrolled in a p...

    K-H Lee, S-J Choi, J-H Lee, S Kim, M Seol, Y-S Lee, W-K Kim in Bone Marrow Transplantation (2004)

  16. No Access

    Article

    Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse

    For patients with acute myeloid leukemia (AML) relapsed after allogeneic bone marrow transplantation (BMT), donor leukocyte infusion (DLI) as sole therapy has very limited efficacy. We tested the effects of cy...

    S-J Choi, J-H Lee, J-H Lee, S Kim, M Seol, Y-S Lee, J-S Lee, W-K Kim, H-S Chi in Leukemia (2004)

  17. No Access

    Article

    Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation

    Severe metabolic abnormalities occurring within 100 days after allogeneic hematopoietic cell transplantation (HCT) were investigated in 311 patients. The metabolic abnormalities included hyper- and hypocalcemi...

    J-H Lee, S-J Choi, J-H Lee, S-E Kim, M Seol, Y-S Lee in Bone Marrow Transplantation (2005)

  18. No Access

    Article

    Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease

    Xenograft models of chronic phase human chronic myeloid leukemia (CML) have been difficult to develop because of the persistence of normal hematopoietic stem cells in most chronic phase CML patients and the la...

    W Eisterer, X Jiang, O Christ, H Glimm, K H Lee, E Pang, K Lambie, G Shaw in Leukemia (2005)

  19. No Access

    Article

    Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia

    Using non-total body irradiation (TBI) containing preparative regimens, 13 patients with severe aplastic anemia (SAA) were transplanted from an alternative donor in a single institute. In total, 12 donors were...

    J-H Lee, S-J Choi, J-H Lee, Y-S Lee, M Seol, S-G Ryu in Bone Marrow Transplantation (2005)

  20. No Access

    Article

    Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study

    Donor leukocyte infusion (DLI) alone has very limited efficacy for patients with acute lymphoblastic leukemia (ALL) who have relapsed after allogeneic bone marrow transplantation (BMT). We, therefore, prospect...

    S-J Choi, J-H Lee, J-H Lee, S Kim, Y-S Lee, M Seol, S-G Ryu in Bone Marrow Transplantation (2005)

previous disabled Page of 3